Conmed (CNMD) Cash from Operations (2010 - 2026)

Conmed's Cash from Operations history runs 17 years deep, the most recent figure standing at 13472000.0 for Q1 2026.

• Quarterly Cash from Operations fell 67.56% year-over-year to 13472000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 142627000.0 (down 20.49% YoY) and the FY2025 annual result came in at 170689000.0, up 2.23% from the prior year.
• Cash from Operations was 13472000.0 for Q1 2026 at Conmed, down from 46335000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 56395000.0 in Q4 2023 and bottomed at 11598000.0 in Q4 2022.
• A 5-year average of 29990705.88 and a median of 29134000.0 in 2025 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2023 — Cash from Operations slumped 1272.87% — and 2024, when it jumped 856.98%.
• Conmed's Cash from Operations stood at 11598000.0 in 2022, then jumped by 586.25% to 56395000.0 in 2023, then retreated by 23.15% to 43338000.0 in 2024, then climbed by 6.92% to 46335000.0 in 2025, then sank by 70.92% to 13472000.0 in 2026.
• Business Quant data shows CNMD's Cash from Operations at 13472000.0 in Q1 2026, 46335000.0 in Q4 2025, and 53686000.0 in Q3 2025.